SYNTHESIS, PHYSICAL AND BIOLOGICAL PROPERTIES OF LITHOCHOLYL-LYSYL-FLUORESCEIN - A FLUORESCENT MONOHYDROXY BILE-SALT ANALOG WITH CHOLESTATIC PROPERTIES
Co. Mills et al., SYNTHESIS, PHYSICAL AND BIOLOGICAL PROPERTIES OF LITHOCHOLYL-LYSYL-FLUORESCEIN - A FLUORESCENT MONOHYDROXY BILE-SALT ANALOG WITH CHOLESTATIC PROPERTIES, Biochimica et biophysica acta (G). General subjects, 1336(3), 1997, pp. 485-496
We have synthesised and characterised a fluorescent monohydroxy bile s
alt analogue, lithocholyl-lysyl-fluorescein and compared its physical
and biological properties with those of lithocholate, glycolithocholat
e, sulpholithocholate, lithocholic acid glucuronide and taurocholate.
The synthetic method used excess N-epsilon-CBZ-L-lysine methyl ester h
ydrochloride and lithocholic acid via N-ethoxycarbonyl-2-ethoxy-1,2-di
hydroquinolone (EEDQ) to give lithocholyl-lysine. Lithocholyllysyl-flu
orescein (LLF) was then prepared using equimolar amounts of lithocholy
l-lysine and fluorescein isothiocyanate (FITC) in bicarbonate buffer.
LLF retained an apple green fluorescence, similar to that of fluoresce
in. Unlike lithocholate, the critical micellar concentrations (CMCs) o
f LLF, glycolithocholate (GLC), lithocholic acid glucuronide (LG) and
sulpholithocholic acid (SLC) were similar. HPLC retention times (t(R)s
) of LLF and GLC were similar with a ratio of LLF/GLC of 1.05. In cont
rast, the t(R) of SLC (6.52 min) but not of LG (21.2 min) was more com
parable to that of taurocholate (5.73 min). In rats under pentobarbita
l anaesthesia, the plasma half-life (t(1/2 alpha)) (min) was 4.5 +/- 1
.3 (n = 6) for LLF, 2.9 +/- 0.4 (n = 5) for [C-14]sulpholithocholate (
C-14-SLC) and 4.3 +/- 0.3 (min) for [C-14]lithocholic acid glucuronide
(C-14-LG). Plasma clearances of C-14-SLC, LLF and C-14-LG were 15.5 /- 2.2 (n = 6), 18.1 +/- 4.2 (n = 6) and 17.8 +/- 0.5 ml/min/kg (n = 6
) (P = 0.15), respectively. Biliary excretion in bile-fistula rats gav
e cumulative 20 min biliary output as a percentage of injected dose as
follows: LLF, 71.6 +/- 0.8% (n = 10); C-14-SLC, 75.5 +/- 2.8% (n = 6)
and C-14-LG, 61.7 +/- 0.5% (n = 6) (P = NS). Peak biliary excretion r
ates, given as % dose/2 min, were 10.2 +/- 0.3 for LLF, 13.5 +/- 0.6 f
or C-14-SLC and 12.8 +/- 0.4 for C-14-LG. In another group of bile-fis
tula rats, a 3.0 mu mol/500 mu l saline i.v. bolus of LLF caused a 15.
4 +/- 1.9% decrease in bile flow and, similarly, sodium lithocholate i
n a solution of albumin caused a 17.9 +/- 1.8% (P = NS) diminution in
bile flow. Despite the similar cholestatic properties of LLF and litho
cholate, LLF was more soluble than lithocholate, with a relative reten
tion time on HPLC similar to that of GLC. LLF is a divalent 'unipolar'
anionic fluorescent monohydroxy bile salt analogue with physical, bio
logical and cholestatic properties that are similar to those of lithoc
holate, glycolithocholate and their derivatives and thus offers a pote
ntially useful probe for studying mechanisms of monohydroxy bile salt-
induced cholestasis at the hepatocellular level. (C) 1997 Elsevier Sci
ence B.V.